• Business
  • Entertainment
  • Health
  • News
  • Sport
  • Tech
  • World
Newsy Today
news of today
Home - Neuroscience
Tag:

Neuroscience

Health

How Infants Develop Rhythmic Movement in Their First Year

by Chief Editor July 7, 2026
written by Chief Editor

Infants begin to shape their movements in response to music within their first year of life, though the ability to coordinate these actions with a rhythmic beat develops later, according to research published in the journal eLife. A study led by Trinh Nguyen of the Istituto Italiano di Tecnologia (IIT) and the University of Vienna tracked 79 infants aged three, six, and 12 months to determine how the brain transforms auditory perception into motor activity.

How does music influence infant movement?

Researchers discovered that while infants process music early in development, spontaneous movement patterns change significantly as they reach their first birthday. By using EEG recordings and automated video-based motion-tracking—specifically DeepLabCut software—the team found that 12-month-olds moved more frequently when listening to music compared to “shuffled” or disorganized versions of the same songs. According to the study, this increased activity was primarily observed in the upper body and limbs, including motions like rocking, swaying, and arm-pedalling.

Did you know?
Infants under 12 months old do not show a significant difference in movement quantity when listening to structured music versus shuffled versions, suggesting that the brain’s ability to “dance” is a developmental milestone that matures over time.

Why does the brain respond to music before movement?

The study suggests that music processing begins well before a child can coordinate complex motor responses. When the research team analyzed event-related potentials (ERPs) from the infants’ EEG data, they found that all age groups—including those as young as three months—exhibited an enhanced auditory response to music. Trinh Nguyen notes that this increasing complexity is likely linked to the maturation of the dorsal auditory stream, a brain pathway essential for rhythmic entrainment.

While the brain recognizes musical structure early on, the motor system takes longer to catch up. The researchers observed no evidence that infants of any age could coordinate their movements precisely in time with the beat. This indicates a two-stage developmental process: first, the brain learns to encode musical information, and later, it gains the motor control necessary to translate that information into synchronized movement.

What are the future implications for developmental research?

Future studies will likely focus on what happens after the first year of life as children begin to develop more intentional, dance-like behaviors. Senior author Giacomo Novembre, a Principal Investigator at IIT, suggests that these early motor responses may represent a biological predisposition for musical engagement. As researchers continue to explore these patterns, they hope to uncover the functional significance of why humans are naturally drawn to move to music.

'Cane Talks: The Music Mothers Make – The Importance of Singing to Infants
Pro Tip:
When observing infant development, focus on the distinction between “spontaneous movement” and “rhythmic coordination.” The former is an early biological response, while the latter is a skill that emerges as motor control refines.

Frequently Asked Questions

Do infants prefer specific types of music?

The study found that infants responded to the structure of music rather than specific pitches. Regardless of whether the music was high or low-pitched, 12-month-olds consistently showed higher movement levels for organized songs compared to shuffled versions.

At what age do babies start dancing to the beat?

The research indicates that even by 12 months of age, infants do not yet coordinate their movements in time with the music. While they move more in response to music at this age, the ability to “keep a beat” develops later in childhood.

Why is this research important for brain science?

Understanding how the brain transforms perception into action provides insight into the fundamentals of human musicality. It helps neuroscientists map how the dorsal auditory stream matures during the first year of life.


Are you interested in the latest developments in early childhood neuroscience? Subscribe to our newsletter for updates on how infants perceive the world, or join the conversation in the comments section below.

July 7, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

BCG Vaccine May Alter Human Brain Immunity

by Chief Editor July 6, 2026
written by Chief Editor

The Bacillus Calmette-Guérin (BCG) vaccine, typically used to prevent tuberculosis, may remodel the brain’s immune environment to potentially lower Alzheimer’s disease risk, according to research published in Communications Medicine. A year-long study led by Mass General Brigham investigators found the vaccine increased immune cell responsiveness and altered Alzheimer’s-related biomarkers in older adults without pre-existing pathology.

How does the BCG vaccine affect brain health?

Researchers observed that the BCG vaccine appears to trigger “trained immunity,” a biological process that boosts the body’s defenses against unrelated infections. According to the study, led by co-first authors Marc Weinberg, MD, PhD, Mahesh Chandra Kodali, PhD, and Zhaozhi Li, PhD, the vaccine promoted enhanced immune responses without causing the inflammatory markers often linked to neurodegeneration.

How does the BCG vaccine affect brain health?

The study involved 23 participants aged 55 and older. The team monitored cerebrospinal fluid (CSF) and blood samples over 12 months. In participants who did not show signs of Alzheimer’s pathology, the vaccine led to a significant decline in amyloid-beta levels in the brain and spinal fluid, while levels of the protein increased in the blood. This suggests the vaccine may assist in the clearance of proteins from the central nervous system.

Did you know?
The BCG vaccine has been studied for over two decades for “off-target” benefits, including ongoing Phase III clinical trials in type 1 diabetes and past Phase II and Phase III trials in COVID-19.

Why was the effect limited to healthy participants?

The research found no measurable effect on amyloid-beta levels in participants who already exhibited evidence of Alzheimer’s pathology. Steven Arnold, MD, senior and co-corresponding author, managing director of the Interdisciplinary Brain Center, Mass General Brigham Neuroscience Institute, noted that these findings suggest the timing of the intervention is critical. The potential for the vaccine to preserve brain health appears highest before significant disease development occurs.

These findings contrast with previous preclinical models and retrospective studies, which suggested a broader reduction in Alzheimer’s risk. While prior research focused largely on blood, this study provides new insight into how immune cells in the fluid surrounding the brain and spinal cord respond to the vaccine.

What are the next steps for this research?

The authors emphasize that these results come from open-label clinical trials and require verification through larger, placebo-controlled studies. Because the study focused on a specific vaccination strategy for older adults, it does not provide data on the long-term effects of childhood BCG vaccinations, which remain common in many parts of sub-Saharan Africa, Southeast Asia, and Eastern Europe.

Study: Certain Vaccines Linked To Reduced Risk Of Alzheimer's

“Although more research is needed, these findings suggest they may also influence biological processes involved in brain aging and neurodegenerative disease,” said Marc Weinberg, a former research scientist at Mass General Brigham who now works at AbbVie.

Pro Tip:
Keep up to date with the latest developments in neuroimmunology by subscribing to our research newsletter for monthly updates on clinical trials and breakthroughs.

Frequently Asked Questions

Does the BCG vaccine cure Alzheimer’s disease?

No. Current research suggests it may help remodel the brain’s immune environment and alter Alzheimer’s-related biomarkers in individuals who do not yet have the disease. It is not a cure for established Alzheimer’s pathology.

Frequently Asked Questions

Is this study definitive?

The study, published in Communications Medicine, provides initial evidence from open-label trials. The researchers state that larger, placebo-controlled studies are necessary to confirm these effects.

What is “trained immunity”?

Trained immunity is a process where the innate immune system is “reprogrammed” to respond more effectively to future, unrelated immune challenges, such as infections or disease markers.


Have questions about the intersection of immunology and brain health? Leave a comment below or explore our archives on neurodegenerative research to learn more about ongoing clinical trials.

July 6, 2026 0 comments
0 FacebookTwitterPinterestEmail
Tech

The Science Behind Why You Flinch at Others’ Pain

by Chief Editor June 20, 2026
written by Chief Editor

Researchers have discovered that the human visual cortex contains eight distinct “body maps” that translate observed actions into simulated touch sensations. According to a study published November 26, 2025, in Nature, this neural mirroring allows the brain to experience empathy by mapping the physical movements of others onto internal sensory templates. This mechanism helps explain why watching someone else get hurt can trigger an involuntary physical flinch.

How the brain translates sight into touch

The human brain does not merely record visual data like a camera; it actively interprets it through the somatosensory cortex. Lead researcher Nicholas Hedger and senior author Tomas Knapen, both associated with the Netherlands Institute for Neuroscience, led the investigation into how this process functions. By analyzing brain scans of volunteers watching Hollywood films like The Social Network, the team identified organized patterns in the visual cortex that mirror the body’s physical layout.

How the brain translates sight into touch

In the somatosensory cortex, specific regions correspond to distinct body parts—a concept known as a homunculus. The discovery of eight similar, parallel maps within the visual cortex suggests that the brain uses these internal templates to “feel” what it sees. This alignment allows the brain to rapidly process whether a person is reaching for an object or expressing an emotion, according to the research published in Nature.

Did you know?

The brain’s reliance on these maps is highly flexible. Researchers believe that by maintaining multiple, overlapping maps, the brain can prioritize different information—such as limb movement versus facial expression—depending on the social context of the moment.

Why do we have multiple body maps?

The existence of eight separate maps suggests a highly specialized system for social cognition. While the research is ongoing, Knapen suggests that these maps act as a “fundamental ingredient” for social interaction. By shifting focus between these maps, the brain can extract specific details about a person’s state, such as their physical posture or the intensity of their emotional expression.

This multi-map system provides a contrast to simpler, single-layer neural models. Rather than being inefficient, the redundancy allows for high-speed “bodily translations.” When you watch a friend cut their finger, your brain uses these visual maps to immediately simulate the sensation of pain, facilitating the empathetic response required for social bonding.

Future applications in medicine and AI

The identification of these maps could shift how scientists approach neurotechnology and mental health. For individuals with autism, who may experience challenges in social processing, these findings offer a new biological framework for understanding those difficulties. Knapen notes that identifying these neural mechanisms could eventually lead to more targeted clinical interventions.

Neuroscientists Talk Shop: Nicholas Priebe on the function of visual cortex.

The implications extend to artificial intelligence as well. Current AI models are largely limited to processing text and video without a “bodily dimension.” Integrating these findings into machine learning could allow for more empathetic AI systems. By training algorithms on brain-imaging datasets that capture how humans physically “feel” visual information, developers may be able to bridge the gap between digital processing and human-like social awareness.

Frequently Asked Questions

Why do I flinch when I see someone else get hurt?
Your visual cortex uses “body maps” to translate the sight of an injury into a simulated touch experience in your somatosensory cortex, causing an involuntary reaction.

Frequently Asked Questions

Are these body maps only for pain?
No. According to the research, these maps translate various visual inputs, including posture, facial expressions, and complex limb movements.

Could this help in treating autism?
Researchers suggest that because these maps are central to social processing, understanding them could help identify new, more effective therapies for social-cognitive differences.

What are your thoughts on how our brains “feel” the world around us? Join the conversation in the comments below or subscribe to our newsletter for more updates on the latest in neuroscience.

June 20, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

Honey Bee Neuronal Gene Expression During Deformed Wing Virus Infection

by Chief Editor June 20, 2026
written by Chief Editor

Deformed Wing Virus type A (DWV-A) triggers behavioral instability in honeybees by disrupting neuronal homeostasis and sensory perception, according to a study published in Scientific Reports. Researchers found that oral infection leads to the downregulation of glutamatergic system genes and creates a “behavioral asynchrony,” where bees simultaneously exhibit traits of both nurses and foragers. This viral impact effectively impairs the colony’s coordination by altering the physiological maturation of individual workers.

How does DWV-A alter bee behavior?

The virus acts directly on the bee’s nervous system, specifically targeting genes responsible for neurotransmission. According to the study, researchers observed a persistent downregulation of eaat-2, neto, and kainate genes by day 10 post-inoculation. These genes are essential for glutamatergic signaling, the primary excitatory neurotransmitter system in the insect brain. When these pathways are suppressed, bees struggle with basic sensory perception, particularly through their antennae, which are critical for navigating the hive and identifying floral resources.

How does DWV-A alter bee behavior?
Did you know?

Honeybees typically undergo a clear transition from “nurse” bees (who care for the brood) to “forager” bees (who collect nectar) as they age. DWV-A infection breaks this cycle, causing bees to express genes for both roles at once, which leads to total loss of labor coordination in the colony.

Why is behavioral asynchrony a threat to colonies?

Colony health relies on a strict division of labor. When worker bees lose their ability to distinguish between nursery duties and foraging, the hive’s internal efficiency collapses. The research highlights that DWV-A induces this asynchrony by scrambling the molecular markers that dictate a bee’s life stage. Unlike other pathogens that cause overt physical deformities, this neurological shift is often invisible to beekeepers until the colony’s productivity begins to decline sharply.

What are the future implications for apiculture?

Understanding the temporal dynamics of DWV-A provides a framework for developing targeted antiviral treatments. By identifying that the most significant gene expression changes occur around day 10, researchers may be able to pinpoint specific windows for intervention. If beekeepers can suppress viral replication before these neurological changes take hold, they might prevent the cascading failure of the colony. Current management strategies, such as USDA-recommended Varroa mite control, remain the primary defense, as mites are the main vector for transmitting DWV-A.

Pro Tip: Monitoring hive health

Don’t rely solely on visual checks for wing deformities. Monitor your colonies for “erratic” behavior, such as foragers returning to the hive without nectar or bees failing to guard the entrance effectively. These may be early signs of neurological stress rather than environmental factors.

Frequently Asked Questions

  • Can infected bees recover from DWV-A? The current study suggests the neurological damage is tied to persistent gene downregulation, which often leads to permanent impairment of the individual bee.
  • Does this virus affect humans? No, DWV-A is specific to Apis mellifera and other bee species and poses no threat to human health.
  • How do I test for DWV-A? Detection requires molecular techniques, such as the RT-qPCR used in the study, to identify viral RNA loads within the bee population.

Are you seeing unusual behavior in your hives? Share your observations in the comments below or subscribe to our newsletter for the latest updates on pollinator health research.

June 20, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

How Immune Cell Aging Drives Parkinson’s: New IU Research

by Chief Editor June 18, 2026
written by Chief Editor

A multi-institutional research team led by the Indiana University School of Medicine has secured a $9 million grant to investigate how immune cell aging contributes to the onset and progression of Parkinson’s disease. The project, supported by Aligning Science Across Parkinson’s (ASAP) and The Michael J. Fox Foundation for Parkinson’s Research, will examine immune-cell exhaustion in both idiopathic and familial cases to identify new targets for precision therapies.

How Does Immune System Aging Influence Parkinson’s?

Age is the primary risk factor for Parkinson’s disease, yet the specific connection between immune system decline and neurodegeneration remains largely unmapped. According to Malú Gámez Tansey, PhD, professor of neurology at IU School of Medicine and the project’s lead primary investigator, the research aims to treat Parkinson’s by addressing dysregulated immune processes. By studying “immune-cell exhaustion”—a state where immune cells lose their ability to function effectively over time—the team hopes to mirror the precision-medicine approach currently utilized in oncology to better predict disease progression.

How Does Immune System Aging Influence Parkinson's?
Did you know?

Parkinson’s disease affects more than 1.1 million people in the United States. In 2024, the annual economic burden, including healthcare, disability, and caregiving costs, reached $82 billion.

Why is Cross-Institutional Collaboration Necessary?

Parkinson’s disease is highly heterogeneous, meaning it manifests differently across the patient population. To address this, the Collaborative Research Network (CRN) is scaling its efforts to create a standardized toolkit for global researchers. Richard Smeyne, PhD, chair of the Department of Neuroscience at Thomas Jefferson University, notes that the complexity of the disease exceeds the capacity of any single institution. The team combines expertise from IU School of Medicine, Columbia University, Thomas Jefferson University, and Tulane University to bridge the gap between pre-clinical laboratory findings and clinical patient outcomes.

Gut-Brain Connection & Microbiomes in Parkinson’s Progression | Dr. Malú Tansey

What Role Do Lifestyle and Environment Play?

While biological aging is a fixed factor, the research team is also investigating whether environmental and lifestyle variables accelerate immune cell burnout. Rebecca Wallings, DPhil, assistant professor of neurology at IU School of Medicine, explains that identifying measurable markers of immune aging could provide a “launch point” for future immunotherapies. By mapping these biological blueprints, the team aims to determine why the disease follows a different trajectory for different individuals.

What Role Do Lifestyle and Environment Play?

Data-Driven Approaches to Disease Mapping

The project integrates biostatistics to manage complex health data, with Travis S. Johnson, PhD, serving as the project’s data manager. This focus on high-quality, standardized data is intended to reduce technical hurdles that have historically stalled drug development. By creating a common baseline for the global research community, the initiative seeks to transition from generalized treatments to therapies tailored to an individual’s specific immune profile.

Pro Tip:

For those tracking the latest developments in neuroimmunology, monitoring the Michael J. Fox Foundation research portal provides the most accurate updates on how these clinical trial phases are evolving.

Frequently Asked Questions

  • What is immune-cell exhaustion in the context of Parkinson’s?
    It refers to the natural decline of immune cell function as individuals age, which researchers believe may contribute to the development or worsening of Parkinson’s disease.
  • Who is funding this research?
    The project is funded by Aligning Science Across Parkinson’s (ASAP) in partnership with The Michael J. Fox Foundation for Parkinson’s Research.
  • Why is this project different from previous studies?
    Unlike singular studies, this project utilizes a multi-institutional, interdisciplinary network to create a standardized “biological blueprint” that can be used by the global scientific community.

Are you interested in how precision medicine is changing the landscape of neurodegenerative care? Subscribe to our newsletter for updates on this study and other breakthroughs in Parkinson’s research.

June 18, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

Copper-Based Drug Clears Alzheimer’s Toxins and Improves Memory

by Chief Editor June 17, 2026
written by Chief Editor

A copper-based drug, Cu(ATSM), has demonstrated the ability to restore the brain’s waste-clearance systems and reduce toxic amyloid-beta protein buildup by 42 percent in laboratory models, according to findings published in ACS Chemical Neuroscience. Researchers at Monash University report that the compound repairs P-glycoprotein (P-gp) pumps at the blood-brain barrier, which are critical for flushing toxins that contribute to Alzheimer’s disease.

How does Cu(ATSM) clear brain toxins?

The drug works by repairing the blood-brain barrier’s specialized transport mechanism. In healthy brains, P-gp pumps act as a waste management system, pushing amyloid-beta out of the brain and into the bloodstream. According to lead author Dr. Jae Pyun, these pumps lose efficacy in Alzheimer’s patients, leading to the toxic protein accumulation associated with cognitive decline. The study found that Cu(ATSM) increased the abundance of these clearance pumps by 24.1 percent, allowing the brain to purge trapped waste more effectively.

Did you know?
Dementia has surpassed coronary heart disease to become the leading cause of death in Australia. This shift highlights the growing urgency for therapies that address the underlying vascular dysfunction in neurodegenerative conditions.

Why is this approach different from previous Alzheimer’s drugs?

Most traditional Alzheimer’s research has focused on directly attacking amyloid plaques or inhibiting their production. This new approach targets the brain’s “plumbing” system instead. By restoring the natural clearance process at the blood-brain barrier, the drug addresses the root cause of protein accumulation rather than just the symptoms. Dr. Pyun’s team noted that this method resulted in a 44 percent improvement in spatial learning over a 56-day period in animal models.

View this post on Instagram about Professor Joseph Nicolazzo
From Instagram — related to Professor Joseph Nicolazzo

When will this treatment move to human trials?

Clinical testing could begin sooner than typical drug candidates because Cu(ATSM) has already passed safety assessments for other neurological conditions, including Parkinson’s disease and ALS. Senior author Professor Joseph Nicolazzo states that since the drug has a proven safety profile, the transition to testing in patients with early symptomatic Alzheimer’s is a logical next step. Because the drug also exhibits anti-inflammatory and neuroprotective properties, it offers a multi-faceted potential treatment for neurovascular dysfunction.

What are the next steps for neurovascular research?

While the reduction in amyloid-beta is significant, researchers are still mapping the specific pathways involved in the protein’s exit from the brain. The team is currently investigating whether the copper compound also stimulates microglia—the brain’s immune cells—to physically break down plaques. Future research will focus on isolating these mechanisms to determine how they contribute to the long-term maintenance of cognitive function.

MVPS2020 – Jae Pyun – Copper Complex Modulates Efflux Transporter at the Blood-Brain Barrier
Pro Tip:
When reviewing new Alzheimer’s research, look for studies that address “neurovascular dysfunction.” This area of study is increasingly viewed as a crucial link between systemic health and cognitive decline, offering a different target than the traditional “amyloid-only” hypothesis.

Frequently Asked Questions

What is the primary function of P-glycoprotein?

P-glycoprotein (P-gp) is a transport protein found at the blood-brain barrier that acts as a pump, moving toxic substances and metabolic waste out of the brain and into the bloodstream.

What is the primary function of P-glycoprotein?

Is Cu(ATSM) already being used in humans?

Yes, the compound has already undergone safety testing for other conditions like Parkinson’s and ALS, which may accelerate its path to clinical trials for Alzheimer’s.

How much did the drug reduce amyloid-beta?

In the study published by the Monash Institute of Pharmaceutical Sciences, the treatment reduced toxic amyloid-beta levels by 42 percent over 56 days.


Have questions about the latest developments in neuro-pharmacology? Subscribe to our weekly research newsletter or leave a comment below to join the discussion on the future of dementia care.

June 17, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

Copper Therapy Enhances Cognitive Function and Learning

by Chief Editor June 15, 2026
written by Chief Editor

Monash University researchers found that the copper compound Cu(ATSM) increases brain clearance pumps by 24.1%, reducing toxic amyloid-beta proteins by 42%. According to a study published in ACS Chemical Neuroscience, this treatment repairs the blood-brain barrier and improves spatial learning by nearly 44% in Alzheimer’s disease models.

How does Cu(ATSM) repair the brain’s waste-clearing system?

Alzheimer’s disease is largely driven by the accumulation of amyloid-beta, a toxic protein that builds up in the brain. In a healthy brain, P-glycoprotein (P-gp) pumps act as a waste-clearing mechanism, flushing these proteins across the blood-brain barrier and into the bloodstream.

In Alzheimer’s patients, these P-gp pumps weaken. This failure “clogs the drain,” trapping toxic proteins inside the brain tissue. Dr. Jae Pyun, a researcher at the Monash Institute of Pharmaceutical Sciences (MIPS), found that the Cu(ATSM) compound successfully engages the brain’s blood vessels to restore this process.

By increasing the abundance of these clearance pumps, the drug allows the brain to expel the trapped waste. Dr. Pyun noted that this repair of the blood-brain barrier is directly linked to the reduction of toxic proteins and improved cognitive function.

Did you know?

Alzheimer’s and other forms of dementia recently became the leading cause of death in Australia, overtaking coronary heart disease.

What specific improvements did the researchers observe?

The laboratory experiments, conducted over a 56-day period, produced measurable biological and behavioral changes. The study’s data shows a direct correlation between pump restoration and cognitive recovery:

What specific improvements did the researchers observe?
  • Pump Abundance: P-gp clearance pumps increased by 24.1%.
  • Protein Reduction: Toxic amyloid-beta levels dropped by 42%.
  • Cognitive Function: Spatial learning improved by nearly 44%.

While the primary mechanism involves the blood-brain barrier, researchers suspect a secondary benefit. They are currently investigating whether the copper treatment empowers microglia—the brain’s own immune cells—to consume and degrade toxic plaques.

Comparing Biological Impacts

The study highlights a significant gap between the physical repair of the barrier and the resulting cognitive benefit. While the P-gp pump abundance increased by roughly one-quarter (24.1%), the resulting reduction in toxic protein was nearly double that rate (42%). This suggests that even modest repairs to the neurovascular system can have outsized effects on protein clearance.

When could this treatment reach human patients?

The transition from laboratory models to human clinical trials may be faster than traditional Alzheimer’s drugs. Professor Joseph Nicolazzo, Director of the Centre for Drug Candidate Optimisation at MIPS, stated that Cu(ATSM) has already undergone safety evaluations for other neurological conditions.

When could this treatment reach human patients?

Because the compound possesses anti-inflammatory and neuroprotective properties, it is already progressing through clinical testing for Parkinson’s disease and Amyotrophic Lateral Sclerosis (ALS). Professor Nicolazzo noted that these existing safety profiles provide a strong rationale for testing the drug in patients with early symptomatic Alzheimer’s disease.

Pro Tip: Researchers often prioritize “repurposing” drugs that have already passed safety trials for other diseases to significantly shorten the development timeline for new treatments.

How does this approach differ from existing Alzheimer’s therapies?

Most current Alzheimer’s research focuses on directly attacking amyloid-beta plaques. This new research shifts the focus toward “neurovascular dysfunction”—the failure of the brain’s plumbing system. Instead of just cleaning up the mess, Cu(ATSM) aims to fix the mechanism that prevents the mess from accumulating in the first place.

How does this approach differ from existing Alzheimer's therapies?

Future studies will attempt to map the exact biological routes these proteins take once they exit the brain. Understanding these precise clearance mechanisms is essential for developing biometal therapies that combat both memory loss and blood vessel dysfunction.

Frequently Asked Questions

What is Cu(ATSM)?

Cu(ATSM) is a copper-based compound with neuroprotective and anti-inflammatory properties currently being studied for neurological diseases.

MVPS2020 – Jae Pyun – Copper Complex Modulates Efflux Transporter at the Blood-Brain Barrier

How does the drug help with memory?

By repairing the P-gp pumps in the blood-brain barrier, the drug helps clear toxic amyloid-beta proteins, which helps restore spatial learning and cognitive function.

Is this drug available for humans yet?

No. These results are from preclinical laboratory experiments. While the drug’s safety profile is known from other studies, human trials for Alzheimer’s are a future step.

Stay updated on the latest medical breakthroughs.

Have thoughts on this new approach to Alzheimer’s treatment? Leave a comment below or subscribe to our newsletter for more deep dives into medical science.

June 15, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

Psilocybin Restores Lost Memories in Alzheimer’s Patient

by Chief Editor June 14, 2026
written by Chief Editor

A recent clinical report involving an octogenarian with advanced Alzheimer’s disease has sparked new scientific debate regarding latent cognitive function. After consuming psilocybin-containing mushrooms, the patient experienced a temporary but significant recovery of speech, memory, and motor skills. Researchers emphasize that this single-patient observation, while compelling, does not constitute a cure for dementia and carries severe health risks if attempted without medical supervision.

How Did Psilocybin Affect the Patient’s Dementia?

According to the report, the patient—a Japanese-American woman in her 80s—had lived with severe Alzheimer’s for a decade and was entirely dependent on caregivers. Approximately 19 hours after ingesting 5 grams of psilocybin-containing mushrooms, she regained the ability to speak in full sentences and recognize family members. This window of lucidity lasted for several weeks, during which she could walk independently and dress herself. These findings, as reported by The Conversation, suggest that the drug may have temporarily bypassed damaged neural pathways to access dormant cognitive abilities.

Did you know?
The patient’s recovery has drawn comparisons to the 1973 clinical trials documented by neurologist Oliver Sacks in his book Awakenings. Sacks observed similar sudden, fluid movement in paralyzed Parkinson’s patients after they were administered the dopamine precursor L-dopa.

What Is the Biological Mechanism Behind This Recovery?

Neuroscientists hypothesize that psilocybin targets the 5-HT2A serotonin receptor, which influences brain plasticity. Research indicates that activating this receptor may trigger the production of brain-derived neurotrophic factor (BDNF), a protein essential for maintaining nerve connections. By temporarily breaking down the rigid boundaries between brain networks, psilocybin may force under-utilized neural clusters to communicate, according to research summaries provided by Neuroscience News. This process, known as neuroplasticity, suggests that even in a damaged brain, some functional infrastructure may remain intact.

What Is the Biological Mechanism Behind This Recovery?

Why Is Self-Medication Dangerous for Dementia Patients?

Medical experts strongly caution against using psilocybin outside of controlled clinical environments. The patient in this report experienced heavy sweating and a prolonged, sleep-like state, which could be fatal for elderly individuals with cardiovascular issues. Because the potency of natural mushrooms varies, there is no way to ensure a safe, standardized dose. Furthermore, the risk of falls, heart stress, and disorienting hallucinations creates a high probability of harm. Currently, no clinical trials have confirmed that psilocybin can reverse the underlying protein accumulation or neuronal death caused by Alzheimer’s disease.

Comparison: Current Research vs. Clinical Reality

Feature Clinical Reality Current Research Status
Alzheimer’s Cure None identified Investigative
Safety Profile High risk of falls/cardiac stress Strictly controlled trials only

Frequently Asked Questions

Does this report prove psilocybin cures Alzheimer’s?

No. Alzheimer’s involves the structural death of neurons and the accumulation of toxic proteins. There is no evidence that psilocybin repairs this damage or reverses the disease process.

Psilocybin & Alzheimer’s Disease

Are there ongoing studies on this topic?

Yes. Researchers at the University of California, Berkeley, are currently examining the effects of synthetic psilocybin on cognitively healthy adults aged 60 to 85. This study uses brain scans and memory tests to assess safety and efficacy in a controlled environment.

Can I replicate these results at home?

No. Attempting to manage dementia with unregulated substances is dangerous. The clinical report emphasizes that the patient’s experience involved severe physical symptoms that require professional medical monitoring.


Stay informed on the latest breakthroughs in neurology and aging research by subscribing to our newsletter. Do you have questions about current clinical trials? Leave a comment below to join the discussion.

June 14, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

How Grandparents Can Support Children’s Mental Health

by Chief Editor June 14, 2026
written by Chief Editor

Dr. Kenneth Barish, Clinical Professor of Psychology at Weill Cornell Medicine, argues that reintegrating grandparents and extended family into daily life is a critical solution to the U.S. Surgeon General’s identified teen mental health crisis. This support helps combat the 40% of American teenagers reporting persistent sadness by providing emotional stability and a sense of purpose through consistent, supportive relationships.

Why is extended family support a priority for adolescent mental health?

The U.S. Surgeon General has identified a prolonged crisis in child and adolescent mental health. Current data indicates that more than 40% of American teenagers report persistent feelings of hopelessness or sadness. Dr. Kenneth Barish suggests this trend stems partly from a societal shift toward individualism.

In his book, The Art and Science of Parenting and Grandparenting, Barish notes that American society has moved from a “we” orientation to an “I” orientation. He argues that the erosion of community and extended family support leaves parents to raise children in isolation, a method he claims contradicts human evolution.

Research indicates that the intense pressure for individual achievement in affluent communities often results in higher rates of substance abuse, anxiety, and depression. Barish posits that the traditional extended family structure provides a necessary buffer against these modern stressors.

Did you know?

According to research reviewed by psychologist Jane Piliavin, helping others is linked to improved self-esteem, lower depression rates, and better immune function in children.

How can grandparents build a child’s “emotional immune system”?

Barish introduces the concept of “molecules of emotional health” to describe the small, frequent moments of listening and encouragement provided by extended family. These interactions act as a defense mechanism against emotional distress.

According to Barish, a child’s most effective protection against emotional “pathogens” is the confident expectation that a trusted adult will listen and understand. He identifies three specific roles grandparents play in this process:

  • Listening: Providing a space where children feel less alone.
  • Problem-solving: Teaching that relationships can be repaired and problems solved.
  • Perspective: Demonstrating that negative emotions are temporary.

Beyond emotional support, Barish suggests that grandparents can foster positive emotions through play and by expressing enthusiastic interest in a child’s specific goals and hobbies.

Pro Tip for Extended Family

Instead of focusing on grades or trophies, focus on the process. Use “growth mindset” language by praising the effort a child puts into a task rather than their innate talent.

What are the risks of unintentional criticism in modern parenting?

While many parents worry about over-praising their children, Barish reports that the most frequent issue in his clinical work is unintentional criticism from well-meaning family members. He states that frequent criticism does not motivate children to improve; instead, it breeds defiance and resentment.

Barish distinguishes between different types of feedback based on Carol Dweck’s research on growth mindsets. To build resilience rather than fragility, he recommends specific communication shifts:

Avoid Praising… Instead, Praise…
Intelligence Effort and persistence
Natural Talent The learning process
Grades/Results Strategy and improvement

How does purpose-driven living combat adolescent anxiety?

Barish argues that personal achievement is a “fragile source of motivation” that often carries a high cost in stress and anxiety. To counter this, he suggests that families should prioritize helping children develop a sense of purpose through service to others.

Secrets to Raising Emotionally Healthy Grandkids: Kenneth Barish on Listening, Kindness & Resilience

He recommends that grandparents and parents engage in volunteering together. These activities, combined with frequent family conversations about kindness and empathy, help strengthen a child’s sense of meaning. Barish asserts these conversations are as vital to development as academic success or behavioral correction.

Rather than clearing a path to success, Barish suggests the goal of caregivers should be to strengthen a child’s inner confidence. This approach aims to help children bounce back from setbacks and pursue interests with greater commitment.

Frequently Asked Questions

How can grandparents help with modern parenting challenges?

Grandparents can provide “molecules of emotional health” by listening, encouraging play, and helping children develop a sense of purpose through community involvement and kindness.

How can grandparents help with modern parenting challenges?

What is the difference between praise that helps and praise that hurts?

Praise that focuses on intelligence or talent can create fragility. Praise that focuses on effort and the learning process fosters a “growth mindset” and resilience.

Why is individual achievement linked to anxiety in teens?

According to Dr. Barish, relying solely on individual achievement as a motivator is fragile and often leads to high levels of stress and emotional instability.

What are your thoughts on the role of extended family in modern upbringing? Share your experiences in the comments below or subscribe to our newsletter for more insights into child development and family wellness.

June 14, 2026 0 comments
0 FacebookTwitterPinterestEmail
Tech

New Hybrid Lens Design Slashes 3D Microscopy Costs

by Chief Editor June 10, 2026
written by Chief Editor

Columbia University researchers have developed a new optical framework, HySIL (Hybrid Solid–Liquid Optics), that enables high-resolution 3D tissue imaging at a fraction of the cost and complexity of traditional systems. By using immersion liquid as an active optical component, the design allows affordable air-based microscope lenses to capture deep-tissue images, according to a study published today in the journal Nature Biotechnology.

How does HySIL change 3D microscopy?

The HySIL framework eliminates the traditional trade-off between image resolution and cost, according to Raju Tomer, a professor of biological sciences at Columbia. Standard “oil-immersion” lenses provide sharp images but are expensive and limited by shallow depth penetration. Conversely, cheaper air-based lenses can reach centimeters into a sample but typically suffer from blurring when imaging transparent tissues. HySIL solves this by pairing a curved solid lens with a precisely matched immersion liquid, creating a continuous optical system that functions regardless of the sample-preparation method, the researchers reported.

Did you know?

Most traditional pathology relies on thin, 2D slices of tissue on glass slides. The new HySIL technology enables 3D imaging, which allows researchers to view the entire tissue architecture, providing a more comprehensive look at disease markers.

What are the practical applications for laboratories?

The team demonstrated the technology using a modular device called SCOPE, which attaches to existing light-sheet microscopes, and a higher-resolution variant, Super-SCOPE. According to the study, these devices have been successfully used to map neural circuits in mouse, salamander, and cavefish brains. Additionally, the technology is being applied to lab-grown human brain tissues and intact human cancer biopsies. Jack Glaser, co-founder and CEO of MBF Bioscience and a co-author on the paper, noted that the system is designed to be used in daily operations by labs without specialized optics expertise.

What are the practical applications for laboratories?

Will this impact future AI diagnostics?

The scalability of 3D imaging is expected to accelerate the development of AI models for medical diagnosis. Hanina Hibshoosh, a professor of pathology and cell biology at Columbia University Irving Medical Center, stated that as AI tools analyze increasingly large amounts of tissue data, the ability to generate affordable 3D images will become vital for disease grading and prognosis. Tomer added that the framework is compatible with various imaging modalities, including confocal and two-photon microscopy, making it a versatile tool for future clinical datasets.

Will this impact future AI diagnostics?

Frequently Asked Questions

What is the main advantage of the HySIL design?
HySIL allows inexpensive air-based lenses to achieve the resolution of high-end, expensive lab systems by using a custom immersion liquid as an active optical component.

Can this technology be used on existing microscopes?
Yes. The researchers developed modular devices like SCOPE that can be added directly to existing light-sheet microscopes. The framework is also designed to be compatible with confocal and two-photon imaging systems.

What types of samples can be imaged with this method?
The team has successfully imaged whole animal brains, miniature lab-grown human brain tissues, and intact human cancer biopsies, according to the research published in Nature Biotechnology.

Pro Tip:

If you are working in a resource-limited setting, look for the commercial version of this technology, known as SLICE, which utilizes the projector-based light-sheet microscope (pLSM) developed by the Tomer group.


Stay informed on the latest breakthroughs in medical imaging and AI diagnostics. Subscribe to our newsletter to receive updates on how emerging technologies are transforming laboratory research and clinical pathology.

June 10, 2026 0 comments
0 FacebookTwitterPinterestEmail
Newer Posts
Older Posts

Recent Posts

  • Major Water and Power Outage Hits Walloon City Following Construction Accident

    July 8, 2026
  • AI-Generated Actress to Star in First Film-Could She Be the Next Scarlett Johansson?

    July 8, 2026
  • Far Cry 7 Shifting Direction as Splinter Cell Stays True to Its Roots

    July 8, 2026
  • PM Modi Proposes New ‘Ganga-Mahakam Vision’ in Historic Indonesia Address

    July 8, 2026
  • Netanyahu Voices Concerns Over US-Turkey F-35 Deal

    July 8, 2026

Popular Posts

  • 1

    Maya Jama flaunts her taut midriff in a white crop top and denim jeans during holiday as she shares New York pub crawl story

    April 5, 2025
  • 2

    Saar-Unternehmen hoffen auf tiefgreifende Reformen

    March 26, 2025
  • 3

    Marta Daddato: vita e racconti tra YouTube e podcast

    April 7, 2025
  • 4

    Unlocking Success: Why the FPÖ Could Outperform Projections and Transform Austria’s Political Landscape

    April 26, 2025
  • 5

    Mecimapro Apologizes for DAY6 Concert Chaos: Understanding the Controversy

    May 6, 2025

Follow Me

Follow Me
  • Cookie Policy
  • CORRECTIONS POLICY
  • PRIVACY POLICY
  • TERMS OF SERVICE

© 2026 Newsy Today. All rights reserved.
For contact, advertising, copyright, issues email: [email protected]


Back To Top

For contact, advertising, copyright, issues email: [email protected]

Newsy Today
  • Business
  • Entertainment
  • Health
  • News
  • Sport
  • Tech
  • World